The US’ Review of March-in Rights, and Some Questions on an Indian Counterpart
SpicyIP
JANUARY 5, 2024
It seems that the domestic pressure resulting from their ever-increasing healthcare costs has reached a point where there is finally some re-examination of how their patent system is affecting costs. which requires patented products to be significantly manufactured in the US until it is commercially infeasible.
Let's personalize your content